TELA Bio, Inc. (TELA): R&D Expense
$9.22M
Year ended 2025-12-31
$9.54M
Trailing 12 months to 2026-06-30
+1.0%
3-year compound annual growth
+16.7%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.22M | +4.6% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $8.81M | -8.4% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $9.62M | +7.6% | 2026-03-25, From 2023-01-01 |
| 2022-12-31 | $8.94M | +32.5% | 2025-03-21, From 2022-01-01 |
| 2021-12-31 | $6.74M | +58.5% | 2024-03-22, From 2021-01-01 |
| 2020-12-31 | $4.25M | +2.5% | 2023-03-23, From 2020-01-01 |
| 2019-12-31 | $4.15M | -4.3% | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $4.34M | -25.0% | 2021-03-25, From 2018-01-01 |
| 2017-12-31 | $5.79M | n/a | 2020-03-30, From 2017-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| TELA Bio, Inc. (TELA) | 2025-12-31 | $9.22M | +4.6% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $3.35M | -8.0% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $14.61M | -18.8% |
| Iradimed Corp (IRMD) | 2025-12-31 | $2.98M | +5.0% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $29.25M | +110.8% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $20.84M | +2.4% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $19.49M | +10.9% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $19.48M | +24.5% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $27.89M | +17.9% |
Compare TELA, PDEX, SGHT, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗